Cited by 473Phytoestrogen effects and researchPhytochemicals and Antioxidant ActivitiesEstrogen and related hormone effects

S-Equol, a potent ligand for estrogen receptor β, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora1–4,

Open access
Setchell, Kenneth DR, Clerici, Carlo, Lephart, Edwin D, Cole, Sidney J, Heenan, Claire, Castellani, Danilo, Wolfe, Brian E, Nechemias-Zimmer, Linda +4 more·2005·The American Journal of Clinical Nutrition

Abstract

Background The discovery of equol in human urine more than 2 decades ago and the finding that it is bacterially derived from daidzin, an isoflavone abundant in soy foods, led to the current nutritional interest in soy foods. Equol, unlike the soy isoflavones daidzein or genistein, has a chiral center and therefore can occur as 2 distinct diastereoisomers.Objective Because it was unclear which enantiomer was present in humans, our objectives were to characterize the exact structure of equol, to examine whether the S- and R-equol enantiomers are bioavailable, and to ascertain whether the differences in their conformational structure translate to significant differences in affinity for estrogen receptors.Design With the use of chiral-phase HPLC and mass spectrometry, equol was isolated from human urine and plasma, and its enantiomeric structure was defined. Human fecal flora were cultured in vitro and incubated with daidzein to ascertain the stereospecificity of the bacterial production of equol. The pharmacokinetics of S- and R- equol were determined in 3 healthy adults after single-bolus oral administration of both enantiomers, and the affinity of each equol enantiomer for estrogen receptors was measured.Results Our studies definitively establish S-equol as the exclusive product of human intestinal bacterial synthesis from soy isoflavones and also show that both enantiomers are bioavailable. S-equol has a high affinity for estrogen receptor beta (K(i) = 0.73 nmol/L), whereas R-equol is relatively inactive.Conclusions Humans have acquired an ability to exclusively synthesize S-equol from the precursor soy isoflavone daidzein, and it is significant that, unlike R-equol, this enantiomer has a relatively high affinity for estrogen receptor beta.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ajcn/81.5.1072

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 6

  1. Uchiyama S, Ueno T, Shirota T. The relationship between soy isofla- vones and the menopausal symptoms in Japanese perimenopausal women. Ann Nutr Metab 2001;45:113 (abstr).
  2. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, Handa RJ. The phytoestrogen equol acts as an anti-androgen to inhibit prostate growth and hormone feedback. Biol Reprod 2004;70:1188 -95.
  3. Clark-Lewis JW. Configurations of optically active flavonoid com- pounds. Rev Pure Appl Chem 1962;12:96 -116.
  4. Baraldi PG, Spalluto G, Cacciari B, Romangnoli R, Setchell KDR. Chemical synthesis of [13C]daidzein. J Med Food 1999;2:99 -102.
  5. Morito K, Hirose T, Kinjo J, et al. Interaction of phytoestrogens with estrogen receptors ␣ and ␤. Biol Pharm Bull 2001;24:351-6.
  6. Ueno T, Uchiyama S. Identification of the specific intestinal bacteria capable of metabolising soy isoflavone to equol. Ann Nutr Metab 2001; 45:114 (abstr).

Cited by

Sorted by citations

Authors
Setchell, K. D., Clerici, C., Lephart, E. D., Cole, S. J., Heenan, C., Castellani, D., Wolfe, B. E., Nechemias-Zimmer, L., Brown, N. M., Lund, T. D., Handa, R. J., & Heubi, J. E.
Affiliations
Brigham Young University (US)
Corresponding author
Setchell, Kenneth DR
Venue
The American Journal of Clinical Nutrition
Publisher
Elsevier BV
Published
2005-05
Volume
81
Issue
5
Pages
1072-1079
ISSN
0002-9165 (ISSN-L)
OpenAlex
W2118089000
Cited by
471
References
59
Citations by year
2026: 21 · 2025: 19 · 2024: 14 · 2023: 24 · 2022: 25 · 2021: 26 · 2020: 22 · 2019: 15 · 2018: 22 · 2017: 16 · 2016: 19 · 2015: 27 · 2014: 21 · 2013: 31 · 2012: 26
FWCI
13.68
Type
journal article
Language
en
Open access
Locations
  • American Journal of Clinical Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca073328-03, RR08084)
  • National Cancer Institute (R01CA73328)
  • National Center for Research Resources (M01RR008084, RR08084)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
S-equol, equol, daidzein, soy isoflavones, estrogen receptor beta, intestinal bacterial metabolism, gut microbiota, enantiomers, stereospecificity, bioavailability, pharmacokinetics, human urine, soy products
MeSH terms
Animals, Biological Availability, Chromatography, High Pressure Liquid, Female, Half-Life, Humans, Intestines, Isoflavones, Male, Gas Chromatography-Mass Spectrometry, Stereoisomerism, Rats, Sprague-Dawley, Area Under Curve, Phytoestrogens, Rats, Equol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review